Genomatix Corporation Relocates to Southwestern Virginia; Genomatix Corporation, a Genetic Materials Manufacturer, Has Relocated Its Operations to Roanoke and Blacksburg, Virginia.Business Editors/Health/Medical Writers ROANOKE, Va.--(BUSINESS WIRE)--May 26, 2004 Genomatix Corporation, a genetic materials manufacturing company, has announced the recent relocation of its production and research operations to Roanoke and Blacksburg, Virginia Blacksburg is an incorporated town located in Montgomery County, Virginia. As of the 2000 census, the town had a total population of 39,573, making it one of Virginia's larger towns. . Genomatix was previously located in Cincinnati, Ohio “Cincinnati” redirects here. For other uses, see Cincinnati (disambiguation). Cincinnati is a city in the U.S. state of Ohio and the county seat of Hamilton County. . The privately held biotech company performs flexible manufacturing of DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. vectors. These highly complex genetic molecules are used by the global life sciences industry to reprogram re·pro·gram tr.v. re·pro·grammed or re·pro·gramed, re·pro·gram·ming or re·pro·gram·ing, re·pro·grams To program again. re the biological activity of cells. Genetic reprogramming Reprogramming refers to erasure and remodeling of epigenetic marks, such as DNA methylation, during mammalian development[1]. After fertilization some cells of the newly formed embryo migrate to the germinal ridge and will eventually become the germ cells plays an increasingly important role in disease research, advanced drug therapies, agriculture, biosecurity, and production of vaccines, antibodies, industrial enzymes and other recombinant proteins Since human recombinants have replaced the animal version in human therapeutics, the prefix of "rh" for "human recombinant" appears less and less in the literature Human recombinants that replaced animal or harvested from human types According to Thomas D. Reed, Ph.D., Genomatix Chairman and Chief Science Officer, the company has spent almost two years considering relocation options in the Eastern United States. "We selected the Roanoke/Blacksburg area for several reasons," said Reed. "Many of our existing and potential customer and partnering relationships are located within an extended life sciences corridor that runs from Upper New Jersey, south to the Atlanta/Birmingham area. Roanoke positions us close to the middle of that corridor, with the added advantage of being in direct proximity to Virginia Tech and UVA-Charlottesville, both of which are very strong life sciences institutions." Reed continued, "We have also been highly impressed with the welcoming response we received from Virginia's state and local leadership, as well as the regional investment community. Everyone made it clear that companies like Genomatix are a key part of Virginia's long-term plan for building a very robust life sciences economy." Reed concluded, " We also couldn't help being attracted to the natural beauty of Southwestern Virginia. All of us are excited to be here and enjoy our first summer in the New River Valley region." Genomatix CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Robert P. Beech, said the relocation went smoothly. "Genomatix is already back in action and manufacturing DNA vector combinations for our growing base of global customers." The company's new contact information can be found at www.genomatix.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion